A Pitfall in Suspected (refractory) Celiac Disease: Losartan-Induced Enteropathy

Am J Gastroenterol. 2017 Nov;112(11):1754-1755. doi: 10.1038/ajg.2017.281.

Authors

T van Gils¹, R J Robijn², G Bouma¹, E A Neefjes-Borst³, C J J Mulder¹

Affiliations

¹ Celiac Center Amsterdam, Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands.
² Department of Gastroenterology and Hepatology, Rijnstate Ziekenhuis, Arnhem, The Netherlands.
³ Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.

PMID: 29109495
DOI: 10.1038/ajg.2017.281

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Angiotensin II Type 1 Receptor Blockers / adverse effects*
Biopsy
Celiac Disease / diagnosis*
Celiac Disease / diet therapy
Diagnosis, Differential
Diarrhea / chemically induced
Diarrhea / diagnosis*
Diet, Gluten-Free
Duodenum / drug effects
Duodenum / pathology
Humans
Hypertension / drug therapy
Intestinal Mucosa / drug effects
Intestinal Mucosa / pathology
Losartan / adverse effects*
Male
Middle Aged
Treatment Outcome

Substances

Angiotensin II Type 1 Receptor Blockers
Losartan

Supplementary concepts

Diarrhea, Chronic, with Villous Atrophy